Crz1 mutant fungal cells
AssigneeMerck Sharp & Dohme Corp.
InventorsBo Jiang, Jun Zhuang
Life of this patent
Estimating the term…
Abstract
The present invention provides CRZ1 mutant fungal host cells, such as Pichia pastoris. The mutant fungal host cells exhibit temperature-resistance, enhanced fermentation robustness and increased expression of heterologous polypeptides such as immunoglobulins. Methods for producing heterologous polypeptides, such as immunoglobulins, using such mutant fungal host cells are within the scope of the present invention.
Claims16
An isolated fungal host cell lacking functional CRZ1 polypeptide with the proviso that the cell comprises functional ATT1 polypeptide.
An isolated polynucleotide which encodes a polypeptide comprising the amino acid sequence set forth in SEQ ID NO:
- 3 which comprises a mutation selected from the group consisting of:
- L33→STOP;
- Q214→STOP;
- L294→STOP;
- S298→STOP;
- E403→G;
- F406→S;
- F406→L;
- C411 -F;
- and
- K469→N.
A method for producing an isolated fungal cell having improved viability under bioprocess fermentation conditions comprising introducing a mutation selected from the group consisting of:
- L33→STOP;
- Q214→STOP;
- L294→STOP;
- S298→STOP;
- E403→G;
- F406→S;
- F406→L;
- C411→F;
- and
- K469-N;
- to endogenous CRZ1 in the fungal cell.
Dependencies are inferred from the claim text.